Details of the Drug

General Information of Drug (ID: DMHBYN5)

Drug Name
NSC-745886
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 278.3
Logarithm of the Partition Coefficient (xlogp) 2.5
Rotatable Bond Count (rotbonds) 0
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 4
Chemical Identifiers
Formula
C17H14N2O2
IUPAC Name
2,2-dimethylnaphtho[3,2-e]benzimidazole-6,11-diol
Canonical SMILES
CC1(N=C2C=CC3=C(C4=CC=CC=C4C(=C3C2=N1)O)O)C
InChI
InChI=1S/C17H14N2O2/c1-17(2)18-12-8-7-11-13(14(12)19-17)16(21)10-6-4-3-5-9(10)15(11)20/h3-8,20-21H,1-2H3
InChIKey
HQLMOIOGHONOJD-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
135433817
TTD ID
D09IJN

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
TERT messenger RNA (TERT mRNA) TTQY2EJ TERT_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Synthesis, cytotoxicity and human telomerase inhibition activities of a series of 1,2-heteroannelated anthraquinones and anthra[1,2-d]imidazole-6,1... Bioorg Med Chem. 2009 Nov 1;17(21):7418-28.